Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(6 sites)
United States
Mayo Clinic Arizona, Phoenix, Arizona Luminis Health Anne Arundel Medical Center, Annapolis, Maryland University of Maryland, Baltimore, Maryland Mayo Clinic Methodist Campus, Rochester, Minnesota Mount Sinai, New York, New York WellSpan Health, York, Pennsylvania Last updated October 2025